Comments

Vigil Neuroscience Stock Price, Quotes and Forecasts

Q: What sector and industry does Vigil Neuroscience (VIGL) operate in?

Vigil Neuroscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VIGLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.11

-0.24-10.21%

At close: -

$2.34

0.2310.90%

After Hours: 8:46 AM EDT

Why is it moving?

Vigil Neuroscience shares are trading lower after the company a Q4 GAAP EPS miss.

Q4 2024 earnings were released today before the market open

Vigil Neuroscience (VIGL) Forecast

News Earnings Vigil Neuroscience (VIGL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Vigil Neuroscience Stock Price, Quotes and Forecasts | NASDAQ:VIGL | Benzinga

Explore Vigil Neuroscience stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIGL.

Open	$2.24
Close	$2.11
Volume / Avg.	156.40K / 1.09M
Day Range	$2.06 - $2.32
52 Wk Range	1.49 - 6.06
Market Cap	$95.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	2.15%
Days to Cover	1.98

Recent News

Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3

Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.

Vandana Singh

Small Neurodegenerative Disease-Focused Vigil Neuroscience Says Alzheimer's Candidate Shows Significant Impact On Disease Bimarker

Vigil Neuroscience reports promising interim results from its Phase 1 trial of VG-3927, showing a strong safety, tolerability, and pharmacokinetic profile in healthy volunteers. The data support continued development of VG-3927 as a potential daily oral therapy for Alzheimer's disease.

Vandana Singh

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.24
Close	$2.11
Volume / Avg.	156.40K / 1.09M
Day Range	$2.06 - $2.32
52 Wk Range	1.49 - 6.06
Market Cap	$95.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	2.15%
Days to Cover	1.98

About Vigil Neuroscience Inc

Sector

Health Care

Industry

Biotechnology

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vigil Neuroscience (VIGL) stock?

You can purchase shares of Vigil Neuroscience (NASDAQ:VIGL) through any online brokerage.

View our list of the best stock brokerages

Who are Vigil Neuroscience (VIGL) competitors?

Other companies in Vigil Neuroscience’s space includes: Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).

What is the forecast, or price target, for Vigil Neuroscience (VIGL) stock?

Vigil Neuroscience has a consensus price target of $15.83.

What is the current price for Vigil Neuroscience (VIGL)?

The stock price for Vigil Neuroscience (NASDAQ: VIGL) is $2.34 last updated March 13, 2025 at 8:46 AM EDT.

Does Vigil Neuroscience (VIGL) pay a dividend?

There are no upcoming dividends for Vigil Neuroscience.

When is Vigil Neuroscience (NASDAQ:VIGL) reporting earnings?

Vigil Neuroscience’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Vigil Neuroscience (VIGL) going to split?

There is no upcoming split for Vigil Neuroscience.

What sector and industry does Vigil Neuroscience (VIGL) operate in?

Vigil Neuroscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vigil Neuroscience Stock Price, Quotes and Forecasts

Vigil Neuroscience (VIGL) Forecast

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

Vigil Neuroscience Stock Price, Quotes and Forecasts | NASDAQ:VIGL | Benzinga

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Vigil Neuroscience (VIGL) stock?

Who are Vigil Neuroscience (VIGL) competitors?

What is the forecast, or price target, for Vigil Neuroscience (VIGL) stock?

What is the current price for Vigil Neuroscience (VIGL)?

Does Vigil Neuroscience (VIGL) pay a dividend?

When is Vigil Neuroscience (NASDAQ:VIGL) reporting earnings?

Is Vigil Neuroscience (VIGL) going to split?

What sector and industry does Vigil Neuroscience (VIGL) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga